TY  - JOUR
AU  - Calderon-Dominguez, Maria
AU  - Trejo-Gutierrez, Eva
AU  - Gonzalez-Rovira, Almudena
AU  - Beltran-Camacho, Lucia
AU  - Rojas-Torres, Marta
AU  - Eslava-Alcon, Sara
AU  - Sanchez-Morillo, Daniel
AU  - Calderon-Dominguez, Juan
AU  - Martinez-Nicolas, Mª Pilar
AU  - Gonzalez-Beitia, Estibaliz
AU  - Nieto-Martin, Mª Dolores
AU  - Trujillo-Soto, Teresa
AU  - Rodriguez-Iglesias, Manuel A
AU  - Moreno, Juan A
AU  - Moreno-Luna, Rafael
AU  - Duran-Ruiz, Mª Carmen
PY  - 2022
DO  - 10.1016/j.omtn.2022.06.006
SN  - 2162-2531
UR  - http://hdl.handle.net/10668/22462
T2  - Molecular therapy. Nucleic acids
AB  - Despite the extraordinary advances achieved to beat COVID-19 disease, many questions remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors determine why individuals respond so differently to the viral infection. Herein,...
LA  - en
PB  - Cell Press
KW  - ACE2
KW  - COVID-19
KW  - MT: Non-coding RNAs
KW  - RAB14
KW  - TMPRSS2
KW  - Biomarkers
KW  - In silico analysis
KW  - MiRNA
KW  - SARS-CoV-2
KW  - Angiotensin-converting enzyme 2
KW  - Virus internalization
KW  - COVID-19
KW  - MicroRNAs
KW  - Virus diseases
KW  - Patient acuity
KW  - Immunoglobulin G
TI  - Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients.
TY  - research article
VL  - 29
ER  -